Abstract
Multiple structural alterations of the heart and the vascular system bring as consequence dysfunctions in the circulatory activity; depending upon the severity of the injury could be necessary the replacement or the intervention of some structures by means of different implants, which can be of biological or synthetic type. The opened possibilities with the appearing of many biomaterials, with great biological compatibility and excellent biomechanical behaviors, allow the use nowadays of a variety of elements for the surgical intervention of patients with several cardiovascular pathologies, increasing their quality of life.
The cardiovascular biomaterials arise from the development of new materials, by means of effective processes that offer new textures, diverse mechanical behaviors, tolerances to strain and to histological-chemical aggression, which guarantees a suitable behavior when being implanted in the human body. An abstract of different biomateriales used within the cardiovascular pathology is given in this paper, as introductory aspect of this exciting subject.
Keywords: Biomaterials. Cardiovascular system. Surgical materials.
References
2.Bustamante J, Villegas A. Prótesis valvulares mecánicas. Rev Col Cardiol 1999;7(4):202-13.
3.Bustamante J, Zapata J. Tejidos biológicos para uso cardiovascular. Gaceta Cardiovascular 1998;(1):5.
4.Hench L, Jones J. Biomaterials, artificial organs and tissue engineering. CRC Press. London 2006. p. 284.
5.Bustamante J, Santamaría J, Juárez A. Diseño y evaluación de bioprótesis valvulares cardíacas “Instituto Nacional de Cardiología Ignacio Chávez”. Rev Méx Ing Biomed 1997;18(1):33-9.
6.Deppisch R, Haug U, Gohl H, Ritz E. Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces. Nephrol Dialysis Transplant 1994;9(Suppl 3):17-23.
7.Gemmell CH, Ramirez SM, Yeo EL, Sefton MV. Platelet activation in whole blood by artificial surfaces: identification of plateletderived microparticles and activated platelet binding to leukocytes as material-induced activation events. J Lab Clin Med 1995;125:276-87.